![](https://d3ilqtpdwi981i.cloudfront.net/STcsNelJs_b1VaY7S1sVmFFnAac=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/6b/09/41/6b094111-c7ac-4859-9d8e-e5902d626db1/thumbnail_afeb6eea-e8b1-4382-bd20-3d82d11aa941.jpg)
Article
Response to "Pervasive Sequence Patents Cover the Entire Human Genome"
All Faculty Scholarship
Document Type
Article
Publication Date
1-1-2014
Disciplines
Abstract
In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.
Citation Information
Response to "Pervasive Sequence Patents Cover the Entire Human Genome," 6 Genome Med. 14 (2014) (co-authored)